Astounding drug-testing tech simulates liver, heart, brain
Photo: Prof. Yaakov Nahmias in his bioengineering lab at the Hebrew University of Jerusalem. Photo by Patricia Alvarado Núñez/graziosopictures.com After spending an average of $2.5 billion to develop a single new drug, sometimes pharma companies have to pull it from the market due to a bad outcome that was not detected in clinical studies. That’s…